Skip to main content
The independent home of the case method - and a charity. Make an impact and  donate
 
 
More search options
Basket icon
No items
Basket icon

Product details

Product details
By continuing to use our site you consent to the use of cookies as described in our privacy policy unless you have disabled them.
You can change your cookie settings at any time but parts of our site will not function correctly without them.
Thumbnail image for product with reference number SM209B
Compact case
Invitrogen/Life Technologies (B)
Case
-
Reference no. SM209B
Subject category: Strategy and General Management
Authors: Robert A Burgelman (Stanford Graduate School of Business, Stanford University); Robert E Siegel (Stanford Graduate School of Business, Stanford University); Rosy Lee (Massachusetts Institute of Technology)
Published by: Stanford Business School
Originally published in: 2012
Version: 20 June 2012
Length: 4 pages
Data source: Field research
Topics: Strategy; Mergers and acquisitions; Acquisitions; Medical industry
Share a link: https://casecent.re/p/122422
| No reviews for this item
This product has not been used yet
View our pricing guide or login to see prices.

Abstract

On June 12, 2008, Invitrogen and Applied Biosystems announced plans to merge. The combined company was to be renamed Life Technologies (NASDAQ: LIFE). Invitrogen offered to acquire Applied Biosystems for $6.7 billion in cash and stock. AB shareholders would receive $38 per share in cash and stock, representing a 17 percent premium over the share's closing price on Wednesday, June 11, 2008.
Other setting(s):
2012
Thumbnail image for product with reference number SM209A
Invitrogen (A)
Case
-
Reference no. SM209A
Subject category: Strategy and General Management
Authors: Robert A Burgelman (Stanford Graduate School of Business, Stanford University); Robert E Siegel (Stanford Graduate School of Business, Stanford University); Rosy Lee (Massachusetts Institute of Technology)
Published by: Stanford Business School
Originally published in: 2012
Version: 25 June 2015
Revision date: 2-Oct-2015
Length: 17 pages
Data source: Field research
Topics: Strategy; Strategy management; Acquisitions; Medical industry
View full details
Thumbnail image for product with reference number SM209C
Compact case
Invitrogen/Life Technologies (C): The 'Best Owner' of the Asset
Case
-
Reference no. SM209C
Subject category: Entrepreneurship
Authors: Robert A Burgelman (Stanford Graduate School of Business, Stanford University); Robert E Siegel (Stanford Graduate School of Business, Stanford University); Rosy Lee (Massachusetts Institute of Technology)
Published by: Stanford Business School
Originally published in: 2014
Version: 12 September 2014
Length: 3 pages
Data source: Field research
Topics: Acquisition; Health care
View full details

About

Abstract

On June 12, 2008, Invitrogen and Applied Biosystems announced plans to merge. The combined company was to be renamed Life Technologies (NASDAQ: LIFE). Invitrogen offered to acquire Applied Biosystems for $6.7 billion in cash and stock. AB shareholders would receive $38 per share in cash and stock, representing a 17 percent premium over the share's closing price on Wednesday, June 11, 2008.

Settings

Other setting(s):
2012

Related

Thumbnail image for product with reference number SM209A
Invitrogen (A)
Case
-
Reference no. SM209A
Subject category: Strategy and General Management
Authors: Robert A Burgelman (Stanford Graduate School of Business, Stanford University); Robert E Siegel (Stanford Graduate School of Business, Stanford University); Rosy Lee (Massachusetts Institute of Technology)
Published by: Stanford Business School
Originally published in: 2012
Version: 25 June 2015
Revision date: 2-Oct-2015
Length: 17 pages
Data source: Field research
Topics: Strategy; Strategy management; Acquisitions; Medical industry
View full details
Thumbnail image for product with reference number SM209C
Compact case
Invitrogen/Life Technologies (C): The 'Best Owner' of the Asset
Case
-
Reference no. SM209C
Subject category: Entrepreneurship
Authors: Robert A Burgelman (Stanford Graduate School of Business, Stanford University); Robert E Siegel (Stanford Graduate School of Business, Stanford University); Rosy Lee (Massachusetts Institute of Technology)
Published by: Stanford Business School
Originally published in: 2014
Version: 12 September 2014
Length: 3 pages
Data source: Field research
Topics: Acquisition; Health care
View full details